Key points are not available for this paper at this time.
The attrition rate was high in supportive care/palliative oncology clinical trials, and was associated with various patient characteristics and a high baseline symptom burden. These findings have implications for future clinical trial design including eligibility criteria and sample size calculation.
Hui et al. (Tue,) studied this question.